Grünenthal expands pain portfolio across Asia-Pacific Partnership brings key medicines to eight markets Read More
Heparegenix completes first darizmetinib treatment in phase 1b Company prepares seamless transition into phase 2a development Read More
Ethiopia, Norway and UK boost global epidemic preparedness Nations commit US$240 million to CEPI’s 2027–2031 strategy Read More
AstronauTx receives funding for Parkinson’s sleep research Grants support studies into restorative sleep and disease mechanisms Read More
Roche welcomes MHRA approval of Gazyvaro New option for patients with systemic lupus erythematosus Read More